Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 3
2015 4
2016 5
2017 7
2018 8
2019 4
2020 2
2021 1
2022 5
2023 8
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort.
Marques ML, Ramiro S, van Lunteren M, Stal RA, Landewé RB, van de Sande M, Fagerli KM, Berg IJ, van Oosterhout M, Exarchou S, Ramonda R, van der Heijde D, van Gaalen FA. Marques ML, et al. Among authors: fagerli km. Ann Rheum Dis. 2024 Apr 11;83(5):589-598. doi: 10.1136/ard-2023-224959. Ann Rheum Dis. 2024. PMID: 38233104
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice.
Christiansen SN, Horskjær Rasmussen S, Pons M, Michelsen B, Glintborg B, Gudbjornsson B, Grondal G, Vencovsky J, Loft AG, Rotar Z, Pirkmajer KP, Nissen MJ, Baranová J, Macfarlane GJ, Jones GT, Iannone F, Caporali R, Laas K, Vorobjov S, Giuseppe DD, Olofsson T, Provan SA, Fagerli KM, Castrejon I, Otero-Varela L, van de Sande M, van der Horst-Bruinsma I, Nordström D, Kuusalo L, Bernardes M, Hetland ML, Østergaard M, Midtbøll Ørnbjerg L. Christiansen SN, et al. Among authors: fagerli km. Semin Arthritis Rheum. 2024 Apr;65:152388. doi: 10.1016/j.semarthrit.2024.152388. Epub 2024 Jan 26. Semin Arthritis Rheum. 2024. PMID: 38301349 Free article.
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care.
Ørnbjerg LM, Rugbjerg K, Georgiadis S, Rasmussen SH, Jacobsson L, Loft AG, Iannone F, Fagerli KM, Vencovsky J, Santos MJ, Möller B, Pombo-Suarez M, Rotar Z, Gudbjornsson B, Cefle A, Eklund K, Codreanu C, Jones G, van der Sande M, Wallman JK, Sebastiani M, Michelsen B, Závada J, Nissen MJ, Sanchez-Piedra C, Tomšič M, Love TJ, Relas H, Mogosan C, Hetland ML, Østergaard M. Ørnbjerg LM, et al. Among authors: fagerli km. J Rheumatol. 2024 Apr 1;51(4):378-389. doi: 10.3899/jrheum.2023-0764. J Rheumatol. 2024. PMID: 38224992 Free article.
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network.
Hellamand P, van de Sande MGH, Ørnbjerg LM, Klausch T, Eklund KK, Relas H, Santos MJ, Vieira-Sousa E, Loft AG, Glintborg B, Østergaard M, Lindström U, Wallman JK, Michelsen B, Fagerli KM, Castrejón I, Gudbjornsson B, Love TJ, Vencovský J, Nekvindová L, Rotar Ž, Tomšič M, Díaz-González F, Kenar G, Tuğsal HY, Iannone F, Ramonda R, Codreanu C, Mogosan C, Nissen MJ, Möller B, Hetland ML, van der Horst-Bruinsma IE. Hellamand P, et al. Among authors: fagerli km. Arthritis Rheumatol. 2024 Apr;76(4):587-598. doi: 10.1002/art.42758. Epub 2024 Feb 25. Arthritis Rheumatol. 2024. PMID: 37975166
Measuring quality of life of patients with axial spondyloarthritis for economic evaluation.
Hernandez Alava M, Wailoo A, Chrysanthou G, Barcelos F, van Gaalen FA, Santos H, Fagerli KM, Gago L, Margarida Cunha M, van de Sande M, Couto MC, Bernardes M, Ramonda R, Exarchou S, Carvalho PD, van der Heijde D, Machado PM. Hernandez Alava M, et al. Among authors: fagerli km. RMD Open. 2022 Feb;8(1):e001955. doi: 10.1136/rmdopen-2021-001955. RMD Open. 2022. PMID: 35177554 Free PMC article.
Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India.
Hoffman SA, LeBoa C, Date K, Haldar P, Harvey P, Shimpi R, An Q, Zhang C, Jayaprasad N, Horng L, Fagerli K, Borhade P, Daruwalla S, Dharmapalan D, Gavhane J, Joshi S, Rai R, Rathod V, Shetty K, Warrier DS, Yadav S, Chakraborty D, Bahl S, Katkar A, Kunwar A, Yewale V, Andrews JR, Bhatnagar P, Dutta S, Luby SP. Hoffman SA, et al. Among authors: fagerli k. Clin Infect Dis. 2023 Jul 5;77(1):138-144. doi: 10.1093/cid/ciad132. Clin Infect Dis. 2023. PMID: 36947143 Free PMC article. Clinical Trial.
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.
Ørnbjerg LM, Rugbjerg K, Georgiadis S, Rasmussen SH, Lindström U, Pavelka K, Yilmaz N, Favalli EG, Nissen MJ, Michelsen B, Vieira-Sousa E, Jones GT, Ionescu R, Relas H, Sanchez-Piedra C, Tomšič M, Geirsson AJ, van der Horst-Bruinsma I, Askling J, Loft AG, Nekvindova L, Direskeneli H, Iannone F, Ciurea A, Fagerli KM, Santos MJ, Macfarlane GJ, Codreanu C, Eklund K, Pombo-Suarez M, Rotar Z, Gudbjornsson B, Rusman T, Østergaard M, Hetland ML. Ørnbjerg LM, et al. Among authors: fagerli km. J Rheumatol. 2023 Aug;50(8):1009-1019. doi: 10.3899/jrheum.220459. Epub 2022 Dec 1. J Rheumatol. 2023. PMID: 36455943
Field Effectiveness of a Typhoid Conjugate Vaccine: The 2018 Navi Mumbai Pediatric TCV Campaign.
Date K, LeBoa C, Hoffman SA, Haldar P, Harvey P, An Q, Zhang C, Yewale VN, Daruwalla S, Dharmapalan D, Gavhane J, Joshi S, Rai R, Rathod V, Shetty K, Warrier DS, Yadav S, Shimpi R, Jayaprasad N, Horng L, Fagerli K, Borhade P, Chakraborty D, Katkar A, Kunwar A, Andrews JR, Bahl S, Bhatnagar P, Dutta S, Luby SP. Date K, et al. Among authors: fagerli k. Am J Trop Med Hyg. 2024 Aug 13;111(4):848-852. doi: 10.4269/ajtmh.24-0181. Print 2024 Oct 2. Am J Trop Med Hyg. 2024. PMID: 39137766 Free PMC article.
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis.
Nissen M, Delcoigne B, Di Giuseppe D, Jacobsson L, Hetland ML, Ciurea A, Nekvindova L, Iannone F, Akkoc N, Sokka-Isler T, Fagerli KM, Santos MJ, Codreanu C, Pombo-Suarez M, Rotar Z, Gudbjornsson B, van der Horst-Bruinsma I, Loft AG, Möller B, Mann H, Conti F, Yildirim Cetin G, Relas H, Michelsen B, Avila Ribeiro P, Ionescu R, Sanchez-Piedra C, Tomsic M, Geirsson ÁJ, Askling J, Glintborg B, Lindström U. Nissen M, et al. Among authors: fagerli km. Rheumatology (Oxford). 2022 Nov 28;61(12):4741-4751. doi: 10.1093/rheumatology/keac174. Rheumatology (Oxford). 2022. PMID: 35323903 Free article.
48 results